GeneOne Life Science, Inc. (KRX:011000)
2,400.00
-70.00 (-2.83%)
Last updated: Aug 14, 2025
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 202.03 billion as of August 15, 2025. Its market cap has increased by 21.67% in one year.
Market Cap
202.03B
Enterprise Value
228.25B
Revenue
37.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,400.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 202.03B, an increase of 5,841.99%. That is a compound annual growth rate of 14.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 14, 2025 | 202.03B | 19.66% |
Dec 30, 2024 | 168.84B | -24.04% |
Dec 28, 2023 | 222.27B | -59.85% |
Dec 29, 2022 | 553.65B | -55.74% |
Dec 30, 2021 | 1,250.93B | 30.16% |
Dec 30, 2020 | 961.06B | 1,733.31% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.52T |
Celltrion | 38.80T |
ALTEOGEN | 23.35T |
Yuhan | 8,487.38B |
Peptron | 8,130.78B |
SK Biopharmaceuticals | 7,846.99B |
PharmaResearch | 6,909.12B |
LigaChem Biosciences | 5,648.08B |